Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The report covers an in depth analysis of 40+ countries
Accessed December 26, 2023
In 2017, a small single-center randomized trial of 62 participants, but with longer follow-up, found benefit with exenatide given once weekly (see graph below)
S.SriretnakumarV.HahnM
In India alone, the GLP-1 therapy market is expected to grow to reach about USD 180 million in 2024 and is estimated to increase by 15-18% every year to 2035 due to awareness, development of healthcare infrastructure, and availability of pricing
As evidence continues to grow, the microbiome is emerging not merely as a bystander, but as a potential determinant of therapeutic responsebringing us closer to a future of truly precision metabolic medicine
US$ 28.90
US$ 26.30
US$ 29.50
US$ 22.91
US$ 21.68
US$ 26.61
